Ambu A/S (AMBU-B.CO)
DKK 121.0
(3.86%)
DKK 121.0
(3.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 235 Million DKK | 39.88% |
| 2023 | 168 Million DKK | 80.65% |
| 2022 | 93 Million DKK | -62.35% |
| 2021 | 247 Million DKK | 2.49% |
| 2020 | 241 Million DKK | -23.97% |
| 2019 | 317 Million DKK | -5.93% |
| 2018 | 337 Million DKK | 11.96% |
| 2017 | 301 Million DKK | 20.4% |
| 2016 | 250 Million DKK | 64.47% |
| 2015 | 152 Million DKK | 0.66% |
| 2014 | 151 Million DKK | 214.58% |
| 2013 | 48 Million DKK | -58.16% |
| 2012 | 114.71 Million DKK | 65.74% |
| 2011 | 69.21 Million DKK | -17.66% |
| 2010 | 84.05 Million DKK | 50.73% |
| 2009 | 55.76 Million DKK | 11.5% |
| 2008 | 50.01 Million DKK | 16.91% |
| 2007 | 42.77 Million DKK | -11.65% |
| 2006 | 48.41 Million DKK | 28.45% |
| 2005 | 37.69 Million DKK | 13.23% |
| 2004 | 33.28 Million DKK | 27.99% |
| 2003 | 26 Million DKK | 73.55% |
| 2002 | 14.98 Million DKK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 92 Million DKK | 15.0% |
| 2024 Q3 | 134 Million DKK | -6.94% |
| 2024 Q2 | 144 Million DKK | 56.52% |
| 2023 Q3 | 51 Million DKK | 240.0% |
| 2023 Q1 | 22 Million DKK | 116.92% |
| 2023 FY | 168 Million DKK | 80.65% |
| 2023 Q4 | 80 Million DKK | 56.86% |
| 2023 Q2 | 15 Million DKK | -31.82% |
| 2022 Q2 | 175 Million DKK | 775.0% |
| 2022 FY | 93 Million DKK | -62.35% |
| 2022 Q3 | 28 Million DKK | -84.0% |
| 2022 Q4 | -130 Million DKK | -564.29% |
| 2022 Q1 | 20 Million DKK | 2100.0% |
| 2021 FY | 247 Million DKK | 2.49% |
| 2021 Q1 | 91 Million DKK | 2933.33% |
| 2021 Q2 | 95 Million DKK | 4.4% |
| 2021 Q3 | 62 Million DKK | -34.74% |
| 2021 Q4 | -1 Million DKK | -101.61% |
| 2020 Q2 | 104 Million DKK | 147.62% |
| 2020 FY | 241 Million DKK | -23.97% |
| 2020 Q4 | 3 Million DKK | -96.74% |
| 2020 Q3 | 92 Million DKK | -11.54% |
| 2020 Q1 | 42 Million DKK | 145.65% |
| 2019 Q2 | 130 Million DKK | 106.35% |
| 2019 Q1 | 63 Million DKK | -44.25% |
| 2019 Q4 | -92 Million DKK | -142.59% |
| 2019 FY | 317 Million DKK | -5.93% |
| 2019 Q3 | 216 Million DKK | 66.15% |
| 2018 Q1 | 19 Million DKK | -78.16% |
| 2018 FY | 337 Million DKK | 11.96% |
| 2018 Q2 | 92 Million DKK | 384.21% |
| 2018 Q3 | 113 Million DKK | 22.83% |
| 2018 Q4 | 113 Million DKK | 0.0% |
| 2017 Q3 | 82 Million DKK | -2.38% |
| 2017 Q1 | 48 Million DKK | -47.83% |
| 2017 Q4 | 87 Million DKK | 6.1% |
| 2017 FY | 301 Million DKK | 20.4% |
| 2017 Q2 | 84 Million DKK | 75.0% |
| 2016 Q4 | 92 Million DKK | 22.67% |
| 2016 Q2 | 52 Million DKK | 67.74% |
| 2016 Q1 | 31 Million DKK | -53.03% |
| 2016 FY | 250 Million DKK | 64.47% |
| 2016 Q3 | 75 Million DKK | 44.23% |
| 2015 FY | 152 Million DKK | 0.66% |
| 2015 Q4 | 66 Million DKK | 230.0% |
| 2015 Q3 | 20 Million DKK | -65.52% |
| 2015 Q2 | 58 Million DKK | 625.0% |
| 2015 Q1 | 8 Million DKK | -90.59% |
| 2014 Q3 | 33 Million DKK | 10.0% |
| 2014 Q4 | 85 Million DKK | 157.58% |
| 2014 FY | 151 Million DKK | 214.58% |
| 2014 Q1 | 3 Million DKK | -88.97% |
| 2014 Q2 | 30 Million DKK | 900.0% |
| 2013 Q3 | 6.6 Million DKK | 200.0% |
| 2013 Q4 | 27.2 Million DKK | 312.12% |
| 2013 FY | 48 Million DKK | -58.16% |
| 2013 Q1 | 11.9 Million DKK | -71.06% |
| 2013 Q2 | 2.2 Million DKK | -81.51% |
| 2012 Q2 | 29.6 Million DKK | 48.0% |
| 2012 Q1 | 20 Million DKK | -23.12% |
| 2012 FY | 114.71 Million DKK | 65.74% |
| 2012 Q4 | 41.11 Million DKK | 71.3% |
| 2012 Q3 | 24 Million DKK | -18.92% |
| 2011 Q4 | 26.01 Million DKK | 15.61% |
| 2011 Q2 | 1.6 Million DKK | -91.58% |
| 2011 FY | 69.21 Million DKK | -17.66% |
| 2011 Q1 | 19 Million DKK | -19.68% |
| 2011 Q3 | 22.5 Million DKK | 1306.25% |
| 2010 Q1 | 12.8 Million DKK | 9.74% |
| 2010 Q2 | 24.5 Million DKK | 91.41% |
| 2010 FY | 84.05 Million DKK | 50.73% |
| 2010 Q4 | 23.65 Million DKK | 2.4% |
| 2010 Q3 | 23.1 Million DKK | -5.71% |
| 2009 Q4 | 11.66 Million DKK | -28.44% |
| 2009 Q1 | 12.1 Million DKK | 0.0% |
| 2009 Q2 | 15.7 Million DKK | 29.75% |
| 2009 FY | 55.76 Million DKK | 11.5% |
| 2009 Q3 | 16.3 Million DKK | 3.82% |
| 2008 FY | 50.01 Million DKK | 16.91% |
| 2007 FY | 42.77 Million DKK | -11.65% |
| 2006 FY | 48.41 Million DKK | 28.45% |
| 2005 FY | 37.69 Million DKK | 13.23% |
| 2004 FY | 33.28 Million DKK | 27.99% |
| 2003 FY | 26 Million DKK | 73.55% |
| 2002 FY | 14.98 Million DKK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ChemoMetec A/S | 136.28 Million DKK | -72.434% |
| Demant A/S | 1.79 Billion DKK | 86.908% |
| GN Store Nord A/S | 228 Million DKK | -3.07% |
| Scandinavian Medical Solutions A/S | 12.22 Million DKK | -1822.398% |
| ViroGates A/S | -12.09 Million DKK | 2042.791% |